(SIKA) Sika - Ratings and Ratios
Adhesives, Sealants, Concrete, Additives, Coatings
Description: SIKA Sika
Sika AG is a global specialty chemicals company that develops, produces, and sells a wide range of products for various industries, including construction and automotive. The companys product portfolio includes admixtures and additives for concrete, waterproofing solutions, adhesives, sealants, and protective coatings, among others.
Key Performance Indicators (KPIs) that can be used to evaluate Sika AGs performance include revenue growth, gross margin, operating margin, and return on equity (RoE). With a RoE of 36.96%, Sika AG demonstrates strong profitability. The companys diversified product portfolio and global presence across various industries, including construction, automotive, and industrial manufacturing, contribute to its stable revenue streams.
Sika AGs product offerings cater to a broad range of applications, including infrastructure projects, commercial and residential construction, and industrial manufacturing. The companys commitment to innovation and quality is reflected in its strong brand presence, with brands like Sika Sarnafil and SikaProof being recognized for their high-performance products.
To further analyze Sika AGs performance, additional KPIs such as debt-to-equity ratio, interest coverage ratio, and dividend yield can be considered. A strong balance sheet with a manageable debt level and a consistent dividend payment history can indicate a stable and mature company. Sika AGs market capitalization of CHF 33 billion and a forward P/E ratio of 24.51 suggest a relatively stable valuation.
Overall, Sika AGs diversified product portfolio, global presence, and strong financial performance make it an attractive investment opportunity in the specialty chemicals sector. Further analysis of the companys financial statements and industry trends can provide more insights into its growth prospects and potential risks.
SIKA Stock Overview
| Market Cap in USD | 38,113m |
| Sub-Industry | Specialty Chemicals |
| IPO / Inception |
SIKA Stock Ratings
| Growth Rating | -43.4% |
| Fundamental | 75.9% |
| Dividend Rating | 39.4% |
| Return 12m vs S&P 500 | -41.0% |
| Analyst Rating | - |
SIKA Dividends
| Dividend Yield 12m | 0.87% |
| Yield on Cost 5y | 0.87% |
| Annual Growth 5y | 7.49% |
| Payout Consistency | 97.5% |
| Payout Ratio | 24.0% |
SIKA Growth Ratios
| Growth Correlation 3m | -94.6% |
| Growth Correlation 12m | -86.8% |
| Growth Correlation 5y | -29% |
| CAGR 5y | -2.05% |
| CAGR/Max DD 5y | -0.04 |
| Sharpe Ratio 12m | -1.82 |
| Alpha | -43.21 |
| Beta | 0.724 |
| Volatility | 25.77% |
| Current Volume | 278.5k |
| Average Volume 20d | 316.3k |
| Stop Loss | 179.9 (-3%) |
| Signal | -2.03 |
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income (2.14b TTM) > 0 and > 6% of Revenue (6% = 1.23b TTM) |
| FCFTA 0.16 (>2.0%) and ΔFCFTA 7.61pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 9.05% (prev 4.55%; Δ 4.50pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.21 (>3.0%) and CFO 3.19b > Net Income 2.14b (YES >=105%, WARN >=100%) |
| Net Debt (5.02b) to EBITDA (2.30b) ratio: 2.18 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.66 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (160.4m) change vs 12m ago 1.08% (target <= -2.0% for YES) |
| Gross Margin 41.45% (prev 38.31%; Δ 3.14pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 129.0% (prev 103.4%; Δ 25.67pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 19.29 (EBITDA TTM 2.30b / Interest Expense TTM 90.6m) >= 6 (WARN >= 3) |
Altman Z'' 3.56
| (A) 0.12 = (Total Current Assets 4.65b - Total Current Liabilities 2.80b) / Total Assets 15.39b |
| (B) 0.40 = Retained Earnings (Balance) 6.23b / Total Assets 15.39b |
| (C) 0.11 = EBIT TTM 1.75b / Avg Total Assets 15.90b |
| (D) 0.68 = Book Value of Equity 6.23b / Total Liabilities 9.22b |
| Total Rating: 3.56 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 75.86
| 1. Piotroski 8.0pt = 3.0 |
| 2. FCF Yield 6.83% = 3.41 |
| 3. FCF Margin 11.72% = 2.93 |
| 4. Debt/Equity 0.84 = 2.16 |
| 5. Debt/Ebitda 2.26 = -0.51 |
| 6. ROIC - WACC 3.98% = 4.97 |
| 7. RoE 33.59% = 2.50 |
| 8. Rev. Trend 45.72% = 2.29 |
| 9. Rev. CAGR 32.41% = 2.50 |
| 10. EPS Trend 4.27% = 0.11 |
| 11. EPS CAGR 26.38% = 2.50 |
What is the price of SIKA shares?
Over the past week, the price has changed by -2.60%, over one month by -6.76%, over three months by -15.57% and over the past year by -30.95%.
Is Sika a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SIKA is around 161.42 CHF . This means that SIKA is currently overvalued and has a potential downside of -12.98%.
Is SIKA a buy, sell or hold?
What are the forecasts/targets for the SIKA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 254.6 | 37.2% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 178.6 | -3.7% |
SIKA Fundamental Data Overview
Market Cap CHF = 30.56b (30.56b CHF * 1.0 CHF.CHF)
CCE Cash And Equivalents = 520.4m CHF (last quarter)
P/E Trailing = 24.9934
P/E Forward = 24.4499
P/S = 2.6331
P/B = 4.9484
P/EG = 4.0978
Beta = 0.99
Revenue TTM = 20.52b CHF
EBIT TTM = 1.75b CHF
EBITDA TTM = 2.30b CHF
Long Term Debt = 5.20b CHF (from longTermDebt, last quarter)
Short Term Debt = unknown (0.0)
Debt = 5.20b CHF (Calculated: Short Term 0.0 + Long Term 5.20b)
Net Debt = 5.02b CHF (from netDebt column, last fiscal year)
Enterprise Value = 35.24b CHF (30.56b + Debt 5.20b - CCE 520.4m)
Interest Coverage Ratio = 19.29 (Ebit TTM 1.75b / Interest Expense TTM 90.6m)
FCF Yield = 6.83% (FCF TTM 2.41b / Enterprise Value 35.24b)
FCF Margin = 11.72% (FCF TTM 2.41b / Revenue TTM 20.52b)
Net Margin = 10.45% (Net Income TTM 2.14b / Revenue TTM 20.52b)
Gross Margin = 41.45% ((Revenue TTM 20.52b - Cost of Revenue TTM 12.01b) / Revenue TTM)
Tobins Q-Ratio = 5.66 (Enterprise Value 35.24b / Book Value Of Equity 6.23b)
Interest Expense / Debt = 1.74% (Interest Expense 90.6m / Debt 5.20b)
Taxrate = 20.18% (from yearly Income Tax Expense: 315.4m / 1.56b)
NOPAT = 1.40b (EBIT 1.75b * (1 - 20.18%))
Current Ratio = 1.66 (Total Current Assets 4.65b / Total Current Liabilities 2.80b)
Debt / Equity = 0.84 (Debt 5.20b / last Quarter total Stockholder Equity 6.17b)
Debt / EBITDA = 2.26 (Net Debt 5.02b / EBITDA 2.30b)
Debt / FCF = 2.16 (Debt 5.20b / FCF TTM 2.41b)
Total Stockholder Equity = 6.38b (last 4 quarters mean)
RoA = 13.93% (Net Income 2.14b, Total Assets 15.39b )
RoE = 33.59% (Net Income TTM 2.14b / Total Stockholder Equity 6.38b)
RoCE = 15.08% (Ebit 1.75b / (Equity 6.38b + L.T.Debt 5.20b))
RoIC = 11.60% (NOPAT 1.40b / Invested Capital 12.03b)
WACC = 7.62% (E(30.56b)/V(35.76b) * Re(8.68%)) + (D(5.20b)/V(35.76b) * Rd(1.74%) * (1-Tc(0.20)))
Shares Correlation 5-Years: -70.0 | Cagr: -0.26%
Discount Rate = 8.68% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 77.30% ; FCFE base≈1.97b ; Y1≈2.15b ; Y5≈2.70b
Fair Price DCF = 260.6 (DCF Value 41.81b / Shares Outstanding 160.4m; 5y FCF grow 10.18% → 3.0% )
Revenue Correlation: 45.72 | Revenue CAGR: 32.41%
Rev Growth-of-Growth: 6.19
EPS Correlation: 4.27 | EPS CAGR: 26.38%
EPS Growth-of-Growth: 165.8